- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Exocrine Pancreatic Insufficiency (EPI) in Finland
Total 85 results
-
Helsinki University Central HospitalCompletedAcute Pancreatitis | Exocrine Pancreatic InsufficiencyFinland
-
Société des Produits Nestlé (SPN)CompletedExocrine Pancreatic InsufficiencyAustralia, New Zealand
-
Helsinki University Central HospitalWithdrawn
-
Helsinki University Central HospitalActive, not recruitingPancreatic Neoplasms | Pancreatic FistulaFinland
-
Helsinki University Central HospitalRecruitingPancreatic Cancer | Pancreatic Duct StrictureFinland
-
Helsinki University Central HospitalUniversity of HelsinkiRecruitingPancreatic Diseases | Pancreas CancerFinland
-
Helsinki University Central HospitalRecruitingThrombosis | Bleeding | Surgery | Pancreas Cancer | Pancreas NeoplasmFinland
-
Roger Williams Medical CenterTriSalus Life SciencesWithdrawnPancreatic AdenocarcinomaUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedMetastatic Pancreatic CancerUnited States
-
Brown UniversityGlaxoSmithKlineCompletedMetastatic Pancreatic CancerUnited States
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode Island; LifespanCompletedMetastatic Pancreatic CancerUnited States
-
Brown UniversityRhode Island HospitalCompletedPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsActive, not recruiting
-
Brown UniversityCompletedPancreatic CancerUnited States
-
Brown UniversityLifespan; SouthCoast Medical Group; Memorial hospitalCompletedMetastatic Pancreatic CancerUnited States
-
Sorrento Therapeutics, Inc.TerminatedMetastatic Pancreatic CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Brown UniversityNational Cancer Institute (NCI)UnknownPancreatic CancerUnited States
-
SanofiCompletedPancreatic NeoplasmsUnited States, Brazil, Poland, Russian Federation, Germany, Turkey, India, Belgium, Czech Republic, Mexico, Chile, Finland, Hungary, Italy, Norway, Canada, Colombia, Peru, Slovakia, Spain, United Kingdom
-
Royal Liverpool University HospitalNCIC Clinical Trials Group; Australasian Gastro-Intestinal Trials GroupCompletedPancreatic CancerFrance, Australia, Canada, Sweden, Switzerland, Finland, Japan, Germany, United Kingdom, Italy, Czech Republic, Greece, Hungary
-
NewLink Genetics CorporationCompleted
-
Infinity Pharmaceuticals, Inc.CompletedMetastatic Pancreatic CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyTerminatedPancreatic Adenocarcinoma | Stage III Pancreatic CancerUnited States
-
Roger Williams Medical CenterUniversity of Colorado, Denver; Sorrento Therapeutics, Inc.Completed
-
KangLaiTe USACompletedPancreatic CancerUnited States
-
Hoffmann-La RocheCompletedPancreatic CancerBelgium, France, Germany, Italy, Spain, Australia, Canada, Czech Republic, Singapore, New Zealand, Austria, China, Netherlands, South Africa, United Kingdom, Israel, Peru, Finland, Poland, Taiwan, Sweden
-
Daiichi Sankyo, Inc.CompletedPancreatic CancerUnited States, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
NewLink Genetics CorporationCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
NantCell, Inc.CompletedPancreatic Cancer | Adenocarcinoma of the Pancreas | Metastatic Pancreatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States, Puerto Rico
-
NCIC Clinical Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v6 and v7United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPancreatic CarcinomaUnited States, Canada, Korea, Republic of, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia...CompletedPancreatic CancerCanada, United States
-
National Cancer Institute (NCI)RecruitingPancreatic Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedPancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingPancreatic Cancer | Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic AdenocarcinomaUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Stage I Pancreatic Cancer AJCC v6 and v7 | Stage II Pancreatic Cancer AJCC v6 and v7United States, Canada, Israel, Belgium
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Sorrento Therapeutics, Inc.WithdrawnBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Carcinoembryonic AntigenUnited States
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingPancreatic Neuroendocrine Tumor | Metastatic Malignant Neoplasm in the Liver | Stage I Pancreatic Neuroendocrine Tumor AJCC v8 | Stage II Pancreatic Neuroendocrine Tumor AJCC v8 | Stage III Pancreatic Neuroendocrine Tumor AJCC v8United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Unresectable Pancreatic Neuroendocrine CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2United States